Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Lung Cancer. 2014 Mar 29;85(1):1–6. doi: 10.1016/j.lungcan.2014.03.021

Figure 2.

Figure 2

Basal levels of SOX2 vary in human NSCLC cell lines. Immunoblot analysis of human NSCLC cell lines with activating mutations in EGFR (H1975, H820, PC9, HCC827, HCC827 GR5, H1650) or Kras (A549, H522).